Tudor Investment Corp
PNT

Tudor Investment Corp’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Tudor Investment Corp’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-52,742
Closed -$478K – 2999
2023
Q2 		$478K Buy
+52,742
New +$465K 0.01% 1730
2022
Q4 		– Sell
-10,282
Closed -$79K – 2963
2022
Q3 		$79K Buy
+10,282
New +$87.3K ﹤0.01% 2164

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's PNT Position: Q3 2023 in Review

Tudor Investment Corp sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2023, closing a stake of 52,742 shares — an estimated $478K sold.

Tudor Investment Corp first reported a position in PNT in Q3 2022 and held it in 2 quarters. The position peaked at $478K in Q2 2023. 125 funds tracked by Wall St. Rank hold PNT as of Q3 2023.

  • Tudor Investment Corp reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 52,742 POINT Biopharma Global Inc. Common Stock shares in Q3 2023, an estimated $478K.
  • Tudor Investment Corp first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Tudor Investment Corp's POINT Biopharma Global Inc. Common Stock position peaked at $478K in Q2 2023.
  • 125 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2023.

Based on Tudor Investment Corp's 13F filing for Q3 2023, filed 15 Nov 2023.